Organization · Venture Capital
Undeterred Capital
Undeterred Capital is a Los Angeles-based investment organization that partners with founders commercializing scientific and technological breakthroughs, focusing on biological platforms and applied robotics.
Overview
What Undeterred Capital does
What Undeterred Capital is
Undeterred Capital is a Los Angeles-based investment organization that partners with founders commercializing scientific and technological breakthroughs, focusing on biological platforms and applied robotics.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Undeterred Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Undeterred Capital as a funder
Investment thesis
Undeterred Capital partners with founders commercializing scientific and technological breakthroughs, focusing on biological platforms and applied robotics.
Focus narrative
Undeterred Capital primarily invests between $500,000 and $1 million in early-stage companies, with a significant focus on pre-seed investments. The firm targets two main areas: Biological Platforms, which includes sectors like material science, synthetic biology, and AI for drug discovery; and Applied Robotics, encompassing autonomy, chemical automation, swarm robotics systems, and biomanufacturing.
Value beyond capital
Undeterred Capital adds value to its portfolio companies through strategic guidance, access to a network of industry experts, and support in navigating the complexities of commercialization in scientific and technological fields.
Terms and economics
- Typical check
- $500,000–$1,000,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: Parallel Bio: Accelerating curative immunotherapies via AI-powered organoid screening. Shinkei: Reinventing fish processing for sustainability. Portal: Engaging in next-generation cell engineering. Curative: Creating sustainable healthcare plans for better health outcomes. Index Biosystems: Managing food supply chain risks using synthetic biology. Zoo: Providing infrastructure for hardware design. Newlight: Decarbonizing the shipping industry through hydrogen integration. AstroForge: Engaging in deep space asteroid mining. Polymath Robotics: Simplifying industrial automation. Circe: Developing scalable gas fermentation for carbon-negative food production.
Common questions
What to know about Undeterred Capital
Upseed classifies Undeterred Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.